Related references
Note: Only part of the references are listed.Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
Rebecca S. Henkhaus et al.
BIOLOGICAL CHEMISTRY (2008)
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Joshua Z. Press et al.
BMC CANCER (2008)
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
F. Rueckert et al.
BRITISH JOURNAL OF CANCER (2008)
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)
Panteieimon Kountourakis et al.
CANCER SCIENCE (2008)
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma
Chris Planque et al.
CLINICAL CANCER RESEARCH (2008)
Human papilloma virus (HPV) status, p16(INK4a), and p53 overexpression in epithelial malignant and borderline ovarian neoplasms
Glovanna Giordano et al.
PATHOLOGY RESEARCH AND PRACTICE (2008)
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy
Yingye Zheng et al.
CLINICAL CANCER RESEARCH (2007)
Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion
Britta Klucky et al.
CANCER RESEARCH (2007)
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
S. J. C. Shan et al.
BRITISH JOURNAL OF CANCER (2007)
Human kallikrein 6 expression in salivary gland tumors
MR Darling et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Human kallikrein 6: A new potential serum biomarker for uterine serous papillary cancer
AD Santin et al.
CLINICAL CANCER RESEARCH (2005)
Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer
K Ogawa et al.
CLINICAL CANCER RESEARCH (2005)
Human kallikrein 13 protein in ovarian cancer cytosols:: A new favorable prognostic marker
A Scorilas et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
Human kallikrein 13 involvement in extracellular matrix degradation
C Kapadia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells
MC Ghosh et al.
TUMOR BIOLOGY (2004)
Human kallikrein 13 expression in normal tissues: An immunohistochemical study
CD Petraki et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
Human kallikrein 13: Production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay
C Kapadia et al.
CLINICAL CHEMISTRY (2003)
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
BR Hoffman et al.
BRITISH JOURNAL OF CANCER (2002)
The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry
CD Petraki et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Increased expression of protease M in ovarian tumors
H Tanimoto et al.
TUMOR BIOLOGY (2001)
Human kallikrein 6 (zyme/protease M/neurosin): A new serum biomarker of ovarian carcinoma
EP Diamandis et al.
CLINICAL BIOCHEMISTRY (2000)
Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
EP Diamandis et al.
CLINICAL BIOCHEMISTRY (2000)
Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues
GM Yousef et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
